Two Sigma Securities’s Axsome Therapeutics AXSM Stock Holding History

Two Sigma Securities’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$908K	Buy	+3,708	New	+$804K	0.08%	329
2026 Q1	–	Sell	-7,650	Closed	-$1.4M	–	1657
2025 Q4	$1.4M	Buy	+7,650	New	+$1.07M	0.19%	122
2025 Q3	–	Sell	-2,228	Closed	-$233K	–	1395
2025 Q2	$233K	Buy	+2,228	New	+$236K	0.03%	828
2024 Q2	–	Sell	-2,938	Closed	-$234K	–	2971
2024 Q1	$234K	Buy	+2,938	New	+$247K	﹤0.01%	2193
2020 Q1	–	Sell	-2,957	Closed	-$306K	–	1375
2019 Q4	$306K	Buy	+2,957	New	+$119K	﹤0.01%	1777
2018 Q2	–	Sell	-20,126	Closed	-$49K	–	2633
2018 Q1	$49K	Buy	+20,126	New	+$60.3K	﹤0.01%	2504

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Securities's AXSM Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 3,708 shares worth $908K. The stake represents 0.08% of the portfolio and ranks #329 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in AXSM as recently as Q4 2025.

Two Sigma Securities first reported a position in AXSM in Q1 2018 and has held it in 6 quarters since. The position peaked at $1.4M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Two Sigma Securities held 3,708 shares of Axsome Therapeutics worth $908K as of Q2 2026.
Axsome Therapeutics was a new Two Sigma Securities position in Q2 2026.
Axsome Therapeutics made up 0.08% of Two Sigma Securities's portfolio in Q2 2026, its #329 holding.
Two Sigma Securities first reported a position in Axsome Therapeutics in Q1 2018 and has held it in 6 quarters since.
Two Sigma Securities's Axsome Therapeutics position peaked at $1.4M in Q4 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.